跳至主要内容
临床试验/JPRN-UMIN000004843
JPRN-UMIN000004843招募中未知

Evaluate of Tolterodine for lower urinary tract syndrome after prostate Brachytherapy - Evaluate and safety of Tolterodine for lower urinary tract syndrome after prostate Brachytherapy

Keio University Shool of Medicine Department of Urology0 个研究点目标入组 32 人开始时间: 2011年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. PVR>or=100cc 2. Patient with urinary tract infection 3. Patient of anti-cholinergic medicine administration taboo a. Patient with urinary retention b. Patient whose pylorus or duodenum or ileum are obstructed, or who has paralytic ileus c. Patient whose digestive organ movement or tention are decreased d. Patient with narrow-angle glaucoma e. Patient with myasthenia gravis f. Patient with severe heart disease g. Patient with sevre hepatic dysfunction (Child-Pugh classification C) h. Patient with hypersentivity for anti-cholinergic medicine

研究者

发起方
Keio University Shool of Medicine Department of Urology

相似试验

Evaluate of Tolterodine for lower urinary tract... | 临床试验